000912542 001__ 912542
000912542 005__ 20231027114348.0
000912542 0247_ $$2doi$$a10.1007/s00415-022-11444-w
000912542 0247_ $$2ISSN$$a0012-1037
000912542 0247_ $$2ISSN$$a0340-5354
000912542 0247_ $$2ISSN$$a0939-1517
000912542 0247_ $$2ISSN$$a1432-1459
000912542 0247_ $$2ISSN$$a1619-800X
000912542 0247_ $$2Handle$$a2128/34030
000912542 0247_ $$2pmid$$a36422669
000912542 0247_ $$2WOS$$aWOS:000887862600002
000912542 037__ $$aFZJ-2022-05715
000912542 082__ $$a610
000912542 1001_ $$00000-0002-1920-0198$$aSchild, Ann-Katrin$$b0$$eCorresponding author
000912542 245__ $$aMultidomain cognitive impairment in non-hospitalized patients with the post-COVID-19 syndrome: results from a prospective monocentric cohort
000912542 260__ $$aBerlin$$bSpringer$$c2023
000912542 264_1 $$2Crossref$$3online$$bSpringer Science and Business Media LLC$$c2022-11-23
000912542 3367_ $$2DRIVER$$aarticle
000912542 3367_ $$2DataCite$$aOutput Types/Journal article
000912542 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1677563823_13022
000912542 3367_ $$2BibTeX$$aARTICLE
000912542 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000912542 3367_ $$00$$2EndNote$$aJournal Article
000912542 520__ $$aBackgroundA fraction of patients with asymptomatic to mild/moderate acute COVID-19 disease report cognitive deficits as part of the post-COVID-19 syndrome. This study aimed to assess the neuropsychological profile of these patients.MethodsAssessment at baseline (three months or more following acute COVID-19) of a monocentric prospective cohort of patients with post-COVID-19 syndrome. Multidomain neuropsychological tests were performed, and questionnaires on depression, anxiety, fatigue, sleep, and general health status were administered.ResultsOf the 58 patients screened, six were excluded due to possible alternative causes of cognitive impairment (major depression, neurodegenerative disease). Of the remaining 52 individuals, only one had a below-threshold screening result on Mini-Mental State Examination, and 13 scored below the cut-off on Montreal Cognitive Assessment. Extended neuropsychological testing revealed a neurocognitive disorder (NCD) in 31 (59.6%) participants with minor NCD in the majority of cases (n = 26). In patients with NCD, the cognitive domains learning/memory and executive functions were impaired in 60.7%, complex attention in 51.6%, language in 35.5%, and perceptual-motor function in 29.0%. Cognitive profiles were associated with daytime sleepiness but not with depression, anxiety, sleep quality, total general health status, or fatigue.ConclusionNeurocognitive impairment can be confirmed in around 60% of individuals with self-reported deficits as part of post-COVID-19 syndrome following a mild acute COVID-19 disease course. Notably, screening tests cannot reliably detect this dysfunction. Standard psychiatric assessments showed no association with cognitive profiles. Longitudinal studies are needed to further evaluate the course of neurocognitive deficits and clarify pathophysiology.
000912542 536__ $$0G:(DE-HGF)POF4-5251$$a5251 - Multilevel Brain Organization and Variability (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000912542 542__ $$2Crossref$$i2022-11-23$$uhttps://creativecommons.org/licenses/by/4.0
000912542 542__ $$2Crossref$$i2022-11-23$$uhttps://creativecommons.org/licenses/by/4.0
000912542 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000912542 7001_ $$00000-0003-3330-8231$$aGoereci, Yasemin$$b1$$eCorresponding author
000912542 7001_ $$0P:(DE-HGF)0$$aScharfenberg, Daniel$$b2
000912542 7001_ $$0P:(DE-HGF)0$$aKlein, Kim$$b3
000912542 7001_ $$0P:(DE-HGF)0$$aLülling, Joachim$$b4
000912542 7001_ $$0P:(DE-HGF)0$$aMeiberth, Dix$$b5
000912542 7001_ $$0P:(DE-HGF)0$$aSchweitzer, Finja$$b6
000912542 7001_ $$0P:(DE-HGF)0$$aStürmer, Sophie$$b7
000912542 7001_ $$0P:(DE-HGF)0$$aZeyen, Philip$$b8
000912542 7001_ $$0P:(DE-HGF)0$$aSahin, Derya$$b9
000912542 7001_ $$0P:(DE-Juel1)131720$$aFink, Gereon R.$$b10$$ufzj
000912542 7001_ $$0P:(DE-HGF)0$$aJessen, Frank$$b11
000912542 7001_ $$0P:(DE-HGF)0$$aFranke, Christiana$$b12
000912542 7001_ $$0P:(DE-HGF)0$$aOnur, Oezguer A.$$b13
000912542 7001_ $$0P:(DE-HGF)0$$aKessler, Josef$$b14
000912542 7001_ $$0P:(DE-HGF)0$$aWarnke, Clemens$$b15
000912542 7001_ $$0P:(DE-HGF)0$$aMaier, Franziska$$b16
000912542 77318 $$2Crossref$$3journal-article$$a10.1007/s00415-022-11444-w$$bSpringer Science and Business Media LLC$$d2022-11-23$$tJournal of Neurology$$x0340-5354$$y2022
000912542 773__ $$0PERI:(DE-600)1421299-7$$a10.1007/s00415-022-11444-w$$p1215-1223$$tJournal of neurology$$v270$$x0340-5354$$y2023
000912542 8564_ $$uhttps://juser.fz-juelich.de/record/912542/files/s00415-022-11444-w.pdf$$yOpenAccess
000912542 909CO $$ooai:juser.fz-juelich.de:912542$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000912542 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131720$$aForschungszentrum Jülich$$b10$$kFZJ
000912542 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$9G:(DE-HGF)POF4-5251$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000912542 9141_ $$y2023
000912542 915__ $$0LIC:(DE-HGF)CCBY4$$2HGFVOC$$aCreative Commons Attribution CC BY 4.0
000912542 915__ $$0StatID:(DE-HGF)0510$$2StatID$$aOpenAccess
000912542 915__ $$0StatID:(DE-HGF)0420$$2StatID$$aNationallizenz$$d2023-10-21$$wger
000912542 915__ $$0StatID:(DE-HGF)0200$$2StatID$$aDBCoverage$$bSCOPUS$$d2023-10-21
000912542 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline$$d2023-10-21
000912542 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR$$bJ NEUROL : 2022$$d2023-10-21
000912542 915__ $$0StatID:(DE-HGF)0600$$2StatID$$aDBCoverage$$bEbsco Academic Search$$d2023-10-21
000912542 915__ $$0StatID:(DE-HGF)0030$$2StatID$$aPeer Review$$bASC$$d2023-10-21
000912542 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bClarivate Analytics Master Journal List$$d2023-10-21
000912542 915__ $$0StatID:(DE-HGF)1050$$2StatID$$aDBCoverage$$bBIOSIS Previews$$d2023-10-21
000912542 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection$$d2023-10-21
000912542 915__ $$0StatID:(DE-HGF)1030$$2StatID$$aDBCoverage$$bCurrent Contents - Life Sciences$$d2023-10-21
000912542 915__ $$0StatID:(DE-HGF)9905$$2StatID$$aIF >= 5$$bJ NEUROL : 2022$$d2023-10-21
000912542 920__ $$lyes
000912542 9201_ $$0I:(DE-Juel1)INM-3-20090406$$kINM-3$$lKognitive Neurowissenschaften$$x0
000912542 980__ $$ajournal
000912542 980__ $$aVDB
000912542 980__ $$aUNRESTRICTED
000912542 980__ $$aI:(DE-Juel1)INM-3-20090406
000912542 9801_ $$aFullTexts
000912542 999C5 $$1S Lopez-Leon$$2Crossref$$9-- missing cx lookup --$$a10.1038/s41598-021-95565-8$$tSci Rep$$uLopez-Leon S, Wegman-Ostrosky T, Perelman C et al (2021) More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. https://doi.org/10.1038/s41598-021-95565-8$$y2021
000912542 999C5 $$1S Phillips$$2Crossref$$9-- missing cx lookup --$$a10.1056/NEJMp2109285$$p577 -$$tN Engl J Med$$uPhillips S, Williams MA (2021) Confronting our next national health disaster—long-haul covid. N Engl J Med 385:577–579. https://doi.org/10.1056/NEJMp2109285$$v385$$y2021
000912542 999C5 $$1JK Logue$$2Crossref$$9-- missing cx lookup --$$a10.1001/jamanetworkopen.2021.0830$$tJAMA Netw Open$$uLogue JK, Franko NM, McCulloch DJ et al (2021) Sequelae in adults at 6 months after COVID-19 infection. JAMA Netw Open 4:e210830. https://doi.org/10.1001/jamanetworkopen.2021.0830$$v4$$y2021
000912542 999C5 $$1A Nalbandian$$2Crossref$$9-- missing cx lookup --$$a10.1038/s41591-021-01283-z$$p601 -$$tNat Med$$uNalbandian A, Sehgal K, Gupta A et al (2021) Post-acute COVID-19 syndrome. Nat Med 27:601–615. https://doi.org/10.1038/s41591-021-01283-z$$v27$$y2021
000912542 999C5 $$1JP Rogers$$2Crossref$$9-- missing cx lookup --$$a10.1016/S2215-0366(20)30203-0$$p611 -$$tLancet Psychiatry$$uRogers JP, Chesney E, Oliver D et al (2020) Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: a systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry 7:611–627. https://doi.org/10.1016/S2215-0366(20)30203-0$$v7$$y2020
000912542 999C5 $$1KE Burdick$$2Crossref$$9-- missing cx lookup --$$a10.1038/s41386-021-00995-7$$p2225 -$$tNeuropsychopharmacology$$uBurdick KE, Millett CE (2021) The impact of COVID-19 on cognition in severe cases highlights the need for comprehensive neuropsychological evaluations in all survivors. Neuropsychopharmacology 46:2225. https://doi.org/10.1038/s41386-021-00995-7$$v46$$y2021
000912542 999C5 $$1MT Heneka$$2Crossref$$9-- missing cx lookup --$$a10.1186/s13195-020-00640-3$$p69 -$$tAlzheimers Res Ther$$uHeneka MT, Golenbock D, Latz E et al (2020) Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther 12:69. https://doi.org/10.1186/s13195-020-00640-3$$v12$$y2020
000912542 999C5 $$1A Jaywant$$2Crossref$$9-- missing cx lookup --$$a10.1038/s41386-021-00978-8$$p2235 -$$tNeuropsychopharmacology$$uJaywant A, Vanderlind WM, Alexopoulos GS et al (2021) Frequency and profile of objective cognitive deficits in hospitalized patients recovering from COVID-19. Neuropsychopharmacology 46:2235–2240. https://doi.org/10.1038/s41386-021-00978-8$$v46$$y2021
000912542 999C5 $$1A Hampshire$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.eclinm.2021.101044$$tEClinicalMedicine$$uHampshire A, Trender W, Chamberlain SR et al (2021) Cognitive deficits in people who have recovered from COVID-19. EClinicalMedicine 39:101044. https://doi.org/10.1016/j.eclinm.2021.101044$$v39$$y2021
000912542 999C5 $$1F Alemanno$$2Crossref$$9-- missing cx lookup --$$a10.1371/journal.pone.0246590$$tPLoS One$$uAlemanno F, Houdayer E, Parma A et al (2021) COVID-19 cognitive deficits after respiratory assistance in the subacute phase: a COVID-rehabilitation unit experience. PLoS One. https://doi.org/10.1371/journal.pone.0246590$$y2021
000912542 999C5 $$1M Almeria$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.bbih.2020.100163$$tBrain Behav Immun Health$$uAlmeria M, Cejudo JC, Sotoca J et al (2020) Cognitive profile following COVID-19 infection: clinical predictors leading to neuropsychological impairment. Brain Behav Immun Health 9:100163. https://doi.org/10.1016/j.bbih.2020.100163$$v9$$y2020
000912542 999C5 $$1EL Graham$$2Crossref$$9-- missing cx lookup --$$a10.1002/acn3.51350$$p1073 -$$tAnn Clin Transl Neurol$$uGraham EL, Clark JR, Orban ZS et al (2021) Persistent neurologic symptoms and cognitive dysfunction in non-hospitalized Covid-19 “long haulers.” Ann Clin Transl Neurol 8:1073–1085. https://doi.org/10.1002/acn3.51350$$v8$$y2021
000912542 999C5 $$1Y-H Liu$$2Crossref$$9-- missing cx lookup --$$a10.1186/s13024-021-00469-w$$p48 -$$tMol Neurodegener$$uLiu Y-H, Wang Y-R, Wang Q-H et al (2021) Post-infection cognitive impairments in a cohort of elderly patients with COVID-19. Mol Neurodegener 16:48. https://doi.org/10.1186/s13024-021-00469-w$$v16$$y2021
000912542 999C5 $$1MS Woo$$2Crossref$$9-- missing cx lookup --$$a10.1093/braincomms/fcaa205$$pfcaa205 -$$tBrain Commun$$uWoo MS, Malsy J, Pöttgen J et al (2020) Frequent neurocognitive deficits after recovery from mild COVID-19. Brain Commun 2:fcaa205. https://doi.org/10.1093/braincomms/fcaa205$$v2$$y2020
000912542 999C5 $$1S Zhao$$2Crossref$$9-- missing cx lookup --$$a10.1093/braincomms/fcab295$$pfcab295 -$$tBrain Commun$$uZhao S, Shibata K, Hellyer PJ et al (2022) Rapid vigilance and episodic memory decrements in COVID-19 survivors. Brain Commun 4:fcab295. https://doi.org/10.1093/braincomms/fcab295$$v4$$y2022
000912542 999C5 $$1R Daroische$$2Crossref$$9-- missing cx lookup --$$a10.3389/fneur.2021.699582$$tFront Neurol$$uDaroische R, Hemminghyth MS, Eilertsen TH et al (2021) Cognitive impairment after COVID-19—a review on objective test data. Front Neurol. https://doi.org/10.3389/fneur.2021.699582$$y2021
000912542 999C5 $$1W Shah$$2Crossref$$9-- missing cx lookup --$$a10.1136/bmj.n136$$tBMJ$$uShah W, Hillman T, Playford ED et al (2021) Managing the long term effects of COVID-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. https://doi.org/10.1136/bmj.n136$$y2021
000912542 999C5 $$1JB Soriano$$2Crossref$$9-- missing cx lookup --$$a10.1016/S1473-3099(21)00703-9$$pe102 -$$tLancet Infect Dis$$uSoriano JB, Murthy S, Marshall JC et al (2022) A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis 22:e102–e107. https://doi.org/10.1016/S1473-3099(21)00703-9$$v22$$y2022
000912542 999C5 $$1M Augustin$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.lanepe.2021.100122$$tLancet Region Health - Europe$$uAugustin M, Schommers P, Stecher M et al (2021) Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Region Health - Europe 6:100122. https://doi.org/10.1016/j.lanepe.2021.100122$$v6$$y2021
000912542 999C5 $$1T Nasserie$$2Crossref$$9-- missing cx lookup --$$a10.1001/jamanetworkopen.2021.11417$$pe2111417 -$$tJAMA Netw Open$$uNasserie T, Hittle M, Goodman SN (2021) Assessment of the frequency and variety of persistent symptoms among patients with COVID-19. JAMA Netw Open 4:e2111417–e2111417. https://doi.org/10.1001/jamanetworkopen.2021.11417$$v4$$y2021
000912542 999C5 $$1ZS Nasreddine$$2Crossref$$9-- missing cx lookup --$$a10.1111/j.1532-5415.2005.53221.x$$p695 -$$tJ Am Geriatr Soc$$uNasreddine ZS, Phillips NA, Bédirian V, Charbonneau S, Whitehead V, Collin I, Cummings JL, Chertkow H (2005) The montreal cognitive assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc 53(4):695–699. https://doi.org/10.1111/j.1532-5415.2005.53221.x [Erratum in: J Am Geriatr Soc. 2019 Sep;67(9):1991. PMID: 15817019]$$v53$$y2005
000912542 999C5 $$1MF Folstein$$2Crossref$$9-- missing cx lookup --$$a10.1016/0022-3956(75)90026-6$$p189 -$$tJ Psychiatric Res$$uFolstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatric Res 12:189–198. https://doi.org/10.1016/0022-3956(75)90026-6$$v12$$y1975
000912542 999C5 $$1American Psychiatric Association$$2Crossref$$9-- missing cx lookup --$$a10.1176/appi.books.9780890425596$$uAmerican Psychiatric Association (2013) Diagnostic and statistical manual of mental disorders, 5th edn. American Psychiatric Publishing, Washington$$y2013
000912542 999C5 $$2Crossref$$uHerrmann-Lingen C, Buss U and Snaith RP (2018) Hospital Anxiety and Depression Scale (HADS) deutsche version: deutschsprachige adaptation der Hospital and Anxiety and Depression Scale (HADS) von R.P. Snaith und A.S. Zigmond, 4. aktuali. Hogrefe Verlag für Psychologie, Göttingen
000912542 999C5 $$1LB Krupp$$2Crossref$$9-- missing cx lookup --$$a10.1001/archneur.1989.00520460115022$$p1121 -$$tArch Neurol$$uKrupp LB (1989) The fatigue severity scale. Arch Neurol 46:1121. https://doi.org/10.1001/archneur.1989.00520460115022$$v46$$y1989
000912542 999C5 $$1DJ Buysse$$2Crossref$$9-- missing cx lookup --$$a10.1016/0165-1781(89)90047-4$$p193 -$$tPsychiatry Res$$uBuysse DJ, Reynolds CF, Monk TH et al (1989) The Pittsburgh sleep quality index: a new instrument for psychiatric practice and research. Psychiatry Res 28:193–213. https://doi.org/10.1016/0165-1781(89)90047-4$$v28$$y1989
000912542 999C5 $$1MW Johns$$2Crossref$$9-- missing cx lookup --$$a10.1093/sleep/14.6.540$$p540 -$$tSleep$$uJohns MW (1991) A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 14:540–545. https://doi.org/10.1093/sleep/14.6.540$$v14$$y1991
000912542 999C5 $$1M Bullinger$$2Crossref$$9-- missing cx lookup --$$a10.1007/BF02959944$$p21 -$$tJ Public Health$$uBullinger M, Kirchberger I, Ware J (1995) Der deutsche SF-36 Health Survey Übersetzung und psychometrische Testung eines krankheitsübergreifenden Instruments zur Erfassung der gesundheitsbezogenen Lebensqualität. J Public Health 3:21–36. https://doi.org/10.1007/BF02959944$$v3$$y1995
000912542 999C5 $$2Crossref$$uSherman RA (2015) multicon: multivariate constructs: R package version 1.6. https://cran.r-project.org/package=multicon
000912542 999C5 $$2Crossref$$uFoundation for Statistical Computing (2021) R: A language and environment for statistical computing [Computer software]. https://www.r-project.org/
000912542 999C5 $$1S Lehrl$$2Crossref$$9-- missing cx lookup --$$a10.1111/j.1600-0404.1995.tb07018.x$$p335 -$$tActa Neurol Scand$$uLehrl S, Triebig G, Fischer B (1995) Multiple choice vocabulary test MWT as a valid and short test to estimate premorbid intelligence. Acta Neurol Scand 91:335–345. https://doi.org/10.1111/j.1600-0404.1995.tb07018.x$$v91$$y1995
000912542 999C5 $$1K-H Schmidt$$2Crossref$$tWST-Wortschatztest$$uSchmidt K-H, Metzler P (1992) WST-Wortschatztest. Beltz Test GmbH, Weinheim$$y1992
000912542 999C5 $$1A Chopra$$2Crossref$$uChopra A, Cavalieri TA, Libon DJ (2007) Dementia screening tools for the primary care physician. Clin Geriatrics 15:38$$y2007
000912542 999C5 $$1S Singer$$2Crossref$$9-- missing cx lookup --$$a10.1038/sj.bjc.6604952$$p908 -$$tBr J Cancer$$uSinger S, Kuhnt S, Götze H et al (2009) Hospital anxiety and depression scale cutoff scores for cancer patients in acute care. Br J Cancer 100:908–912. https://doi.org/10.1038/sj.bjc.6604952$$v100$$y2009
000912542 999C5 $$1F Ceban$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.bbi.2021.12.020$$p93 -$$tBrain Behav Immun$$uCeban F, Ling S, Lui LM et al (2022) Fatigue and cognitive impairment in Post-COVID-19 syndrome: a systematic review and meta-analysis. Brain Behav Immun 101:93–135. https://doi.org/10.1016/j.bbi.2021.12.020$$v101$$y2022
000912542 999C5 $$1SJ Yong$$2Crossref$$9-- missing cx lookup --$$a10.1080/23744235.2021.1924397$$p737 -$$tInfect Dis (Lond)$$uYong SJ (2021) Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis (Lond) 53:737–754. https://doi.org/10.1080/23744235.2021.1924397$$v53$$y2021
000912542 999C5 $$1F Mattioli$$2Crossref$$9-- missing cx lookup --$$a10.1007/s00415-021-10579-6$$p4422 -$$tJ Neurol$$uMattioli F, Stampatori C, Righetti F, Sala E, Tomasi C, De Palma G (2021) Neurological and cognitive sequelae of Covid-19: a four month follow-up. J Neurol 268(12):4422–4428. https://doi.org/10.1007/s00415-021-10579-6$$v268$$y2021
000912542 999C5 $$1RS McIntyre$$2Crossref$$9-- missing cx lookup --$$a10.1017/S1092852918001189$$p154 -$$tCNS Spectr$$uMcIntyre RS, Anderson N, Baune BT et al (2019) Expert consensus on screening and assessment of cognition in psychiatry. CNS Spectr 24:154–162. https://doi.org/10.1017/S1092852918001189$$v24$$y2019
000912542 999C5 $$1S Hoops$$2Crossref$$9-- missing cx lookup --$$a10.1212/WNL.0b013e3181c34b47$$p1738 -$$tNeurology$$uHoops S, Nazem S, Siderowf AD et al (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73:1738–1745. https://doi.org/10.1212/WNL.0b013e3181c34b47$$v73$$y2009
000912542 999C5 $$1L Morin$$2Crossref$$9-- missing cx lookup --$$a10.1001/jama.2021.3331$$p1525 -$$tJ Am Med Assoc$$uMorin L, Savale L, Pham T et al (2021) Four-month clinical status of a cohort of patients after hospitalization for COVID-19. J Am Med Assoc 325:1525–1534. https://doi.org/10.1001/jama.2021.3331$$v325$$y2021
000912542 999C5 $$1V Rass$$2Crossref$$9-- missing cx lookup --$$a10.1111/ene.14803$$p3348 -$$tEur J Neurol$$uRass V, Beer R, Schiefecker AJ, Kofler M, Lindner A, Mahlknecht P, Heim B, Limmert V, Sahanic S, Pizzini A, Sonnweber T, Tancevski I, Scherfler C, Zamarian L, Bellmann-Weiler R, Weiss G, Djamshidian A, Kiechl S, Seppi K et al (2021) Neurological outcome and quality of life 3 months after COVID-19: A prospective observational cohort study. Eur J Neurol 28(10):3348–3359. https://doi.org/10.1111/ene.14803$$v28$$y2021
000912542 999C5 $$1JH Becker$$2Crossref$$9-- missing cx lookup --$$a10.1001/jamanetworkopen.2021.30645$$tJAMA Netw Open$$uBecker JH, Lin JJ, Doernberg M et al (2021) Assessment of cognitive function in patients after COVID-19 infection. JAMA Netw Open. https://doi.org/10.1001/jamanetworkopen.2021.30645$$y2021
000912542 999C5 $$1R Ferrucci$$2Crossref$$9-- missing cx lookup --$$a10.3390/brainsci11020235$$p235 -$$tBrain Sci$$uFerrucci R, Dini M, Groppo E et al (2021) Long-lasting cognitive abnormalities after COVID-19. Brain Sci 11:235. https://doi.org/10.3390/brainsci11020235$$v11$$y2021
000912542 999C5 $$1P Voruz$$2Crossref$$9-- missing cx lookup --$$a10.1093/braincomms/fcac057$$pfcac057 -$$tBrain Commun$$uVoruz P, Cionca A, Jacot de Alcântara I et al (2022) Functional connectivity underlying cognitive and psychiatric symptoms in post-COVID-19 syndrome: is anosognosia a key determinant? Brain Commun 4:fcac057. https://doi.org/10.1093/braincomms/fcac057$$v4$$y2022
000912542 999C5 $$1F Schweitzer$$2Crossref$$9-- missing cx lookup --$$a10.1002/ana.26262$$p150 -$$tAnn Neurol$$uSchweitzer F, Goereci Y, Franke C et al (2022) Cerebrospinal fluid analysis post-COVID-19 is not suggestive of persistent central nervous system infection. Ann Neurol 91:150–157. https://doi.org/10.1002/ana.26262$$v91$$y2022
000912542 999C5 $$1S Jarius$$2Crossref$$9-- missing cx lookup --$$a10.1186/s12974-021-02339-0$$p19 -$$tJ Neuroinflamm$$uJarius S, Pache F, Körtvelyessy P et al (2022) Cerebrospinal fluid findings in COVID-19: a multicenter study of 150 lumbar punctures in 127 patients. J Neuroinflamm 19:19. https://doi.org/10.1186/s12974-021-02339-0$$v19$$y2022
000912542 999C5 $$1A Varatharaj$$2Crossref$$9-- missing cx lookup --$$a10.1016/S2215-0366(20)30287-X$$p875 -$$tThe Lancet Psychiatry$$uVaratharaj A, Thomas N, Ellul MA et al (2020) Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study. The Lancet Psychiatry 7:875–882. https://doi.org/10.1016/S2215-0366(20)30287-X$$v7$$y2020
000912542 999C5 $$1WJ Murphy$$2Crossref$$9-- missing cx lookup --$$a10.1056/NEJMcibr2113694$$p394 -$$tN Engl J Med$$uMurphy WJ, Longo DL (2022) A possible role for anti-idiotype antibodies in SARS-CoV-2 infection and vaccination. N Engl J Med 386:394–396. https://doi.org/10.1056/NEJMcibr2113694$$v386$$y2022
000912542 999C5 $$1D Scharfenberg$$2Crossref$$9-- missing cx lookup --$$a10.23668/psycharchives.8221$$tEur J Psychol$$uScharfenberg D, Schild A-K, Warnke C, Maier F (2022) A network perspective on neuropsychiatric and cognitive symptoms of the post-COVID syndrome. Eur J Psychol. https://doi.org/10.23668/psycharchives.8221$$y2022
000912542 999C5 $$1KW Miskowiak$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.euroneuro.2021.03.019$$p39 -$$tEur Neuropsychopharmacol$$uMiskowiak KW, Johnsen S, Sattler SM et al (2021) Cognitive impairments four months after COVID-19 hospital discharge: Pattern, severity and association with illness variables. Eur Neuropsychopharmacol 46:39–48. https://doi.org/10.1016/j.euroneuro.2021.03.019$$v46$$y2021
000912542 999C5 $$1J Matta$$2Crossref$$9-- missing cx lookup --$$a10.1001/jamainternmed.2021.6454$$p19 -$$tJAMA Intern Med$$uMatta J, Wiernik E, Robineau O et al (2022) Association of self-reported COVID-19 infection and SARS-CoV-2 serology test results with persistent physical symptoms among french adults during the COVID-19 pandemic. JAMA Intern Med 182:19–25. https://doi.org/10.1001/jamainternmed.2021.6454$$v182$$y2022
000912542 999C5 $$1LA Jason$$2Crossref$$9-- missing cx lookup --$$a10.1080/21641846.2021.1922140$$p59 -$$tFatigue$$uJason LA, Islam M, Conroy K et al (2021) COVID-19 symptoms over time: comparing long-haulers to ME/CFS. Fatigue 9:59–68. https://doi.org/10.1080/21641846.2021.1922140$$v9$$y2021
000912542 999C5 $$1G Douaud$$2Crossref$$9-- missing cx lookup --$$a10.1101/2021.06.11.21258690$$tmedRxiv$$uDouaud G, Lee S, Alfaro-Almagro F et al (2022) SARS-CoV-2 is associated with changes in brain structure in UK Biobank. medRxiv. https://doi.org/10.1101/2021.06.11.21258690$$y2022
000912542 999C5 $$1C Franke$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.bbi.2020.12.022$$p415 -$$tBrain Behav Immun$$uFranke C, Ferse C, Kreye J et al (2021) High frequency of cerebrospinal fluid autoantibodies in COVID-19 patients with neurological symptoms. Brain Behav Immun 93:415–419. https://doi.org/10.1016/j.bbi.2020.12.022$$v93$$y2021
000912542 999C5 $$1M Taquet$$2Crossref$$9-- missing cx lookup --$$a10.1371/journal.pmed.1003773$$tPLoS Med$$uTaquet M, Dercon Q, Luciano S et al (2021) Incidence, co-occurrence, and evolution of long-COVID features: a 6-month retrospective cohort study of 273,618 survivors of COVID-19. PLoS Med. https://doi.org/10.1371/journal.pmed.1003773$$y2021
000912542 999C5 $$1A Costas-Carrera$$2Crossref$$9-- missing cx lookup --$$a10.1016/j.bbih.2022.100425$$tBrain Behav Immun Health$$uCostas-Carrera A, Sánchez-Rodríguez MM, Cañizares S et al (2022) Neuropsychological functioning in post-ICU patients after severe COVID-19 infection: the role of cognitive reserve. Brain Behav Immun Health 21:100425. https://doi.org/10.1016/j.bbih.2022.100425$$v21$$y2022
000912542 999C5 $$1X Chen$$2Crossref$$9-- missing cx lookup --$$a10.1007/s00415-020-10067-3$$p392 -$$tJ Neurol$$uChen X, Laurent S, Onur OA et al (2021) A systematic review of neurological symptoms and complications of COVID-19. J Neurol 268:392–402. https://doi.org/10.1007/s00415-020-10067-3$$v268$$y2021